Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis

BACKGROUND: Ruxolitinib cream is a topical formulation of ruxolitinib, a Janus kinase (JAK) 1/JAK2 inhibitor. OBJECTIVES: To report timing and magnitude of effect of ruxolitinib cream on itch in patients with atopic dermatitis (AD), a highly pruritic inflammatory skin disease. METHODS: Two phase 3 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Blauvelt, Andrew, Kircik, Leon, Papp, Kim A., Simpson, Eric L., Silverberg, Jonathan I., Kim, Brian S., Kwatra, Shawn G., Kuligowski, Michael E., Venturanza, May E., Wei, Shaoceng, Szepietowski, Jacek C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles and Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087253/
https://www.ncbi.nlm.nih.gov/pubmed/36066323
http://dx.doi.org/10.1111/jdv.18571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087253/
https://www.ncbi.nlm.nih.gov/pubmed/36066323
http://dx.doi.org/10.1111/jdv.18571

Ejemplares similares